Reinduction Platform for Children With First Marrow Relapse of Acute Lymphoblastic Leukemia: A Children's Oncology Group Study

PURPOSE: Treatment of childhood relapsed acute lymphoblastic leukemia (ALL) remains a significant challenge. The goal of the Children's Oncology Group (COG) AALL01P2 study was to develop a safe and active chemotherapy reinduction platform, which could be used to evaluate novel agents in future...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Raetz, Elizabeth A., Borowitz, Michael J., Devidas, Meenakshi, Linda, Stephen B., Hunger, Stephen P., Winick, Naomi J., Camitta, Bruce M., Gaynon, Paul S., Carroll, William L.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: American Society of Clinical Oncology 2008
Konular:
Pediatric Oncology
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC2654313/
https://ncbi.nlm.nih.gov/pubmed/18711187
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2008.16.1414
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller